CDT Equity (CDT) Interest Expenses (2022 - 2026)
CDT Equity's (CDT) quarterly Interest Expenses came in at $400000.0 in Q1 2026, down 63.64% YoY from $1.1 million in Q1 2025, and up 132.0% on a QoQ basis from -$1.2 million in Q4 2025.
CDT Equity (CDT) Interest Expenses (2022 - 2026) Analysis & Trends
CDT Equity (CDT) has 5 years of Interest Expenses data on file, last reported at $400000.0 in Q1 2026.
- Quarterly Interest Expenses fell 63.64% year-over-year to $400000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $430000.0 (down 95.7% YoY) and the FY2025 annual result came in at $9.0 million, up 51.9% from the prior year.
- Interest Expenses climbed to $400000.0 in Q1 2026, from -$1.2 million in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $40.0 million in Q1 2024 to a low of -$1.5 million in Q4 2023.
- A 5-year average of $3.3 million and a median of $554000.0 in 2024 frame the typical range for Interest Expenses.
- Annual changes were most pronounced in 2023 — Interest Expenses tumbled 209.32% — and 2024, when it soared 13551.88%.
- Tracing CDT's Interest Expenses over 5 years: stood at $1.4 million in 2022, then plunged by 209.32% to -$1.5 million in 2023, then surged by 492.28% to $5.8 million in 2024, then slumped by 121.39% to -$1.2 million in 2025, then soared by 132.0% to $400000.0 in 2026.
- The last three Interest Expenses figures came in at $400000.0 (Q1 2026), -$1.2 million (Q4 2025), and $189000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.81 Bn | 130.96 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.07 Bn | 78.08 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 65.47 Bn | 60.29 Bn | 1.37 Bn | - |
| 4 | Moderna | 55.64 Bn | 50.50 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.99 Bn | 36.89 Bn | 1.53 Bn | 39.74 Mn |
| 6 | Alnylam Pharmaceuticals | 31.68 Bn | 28.37 Bn | 992.69 Mn | 82.05 Mn |
| 7 | BioNTech SE | 27.69 Bn | 9.29 Bn | 668.28 Mn | -4.89 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 20.27 Mn |
| 9 | Royalty Pharma | 27.36 Bn | 26.52 Bn | - | 93.62 Mn |
| 10 | CDT Equity | 1.63 Mn | 1.63 Mn | - | 1.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.54 Mn |
| Jun 30, 2026 | 1.54 Mn |
| Mar 31, 2026 | 400,000.00 |
| Mar 31, 2026 | 400,000.00 |
| Dec 31, 2025 | -1.25 Mn |
| Dec 31, 2025 | -1.25 Mn |
| Sep 30, 2025 | 189,000.00 |
| Sep 30, 2025 | 189,000.00 |
| Jun 30, 2025 | 1.09 Mn |
| Jun 30, 2025 | 1.09 Mn |
| Mar 31, 2025 | 1.10 Mn |
| Mar 31, 2025 | 1.10 Mn |
| Dec 31, 2024 | 5.85 Mn |
| Dec 31, 2024 | 5.85 Mn |
| Sep 30, 2024 | 708,000.00 |
| Sep 30, 2024 | 708,000.00 |
| Jun 30, 2024 | 2.34 Mn |
| Jun 30, 2024 | 2.34 Mn |
| Mar 31, 2024 | 40.00 Mn |
| Mar 31, 2024 | 40.00 Mn |